<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00487981</url>
  </required_header>
  <id_info>
    <org_study_id>SCS0206</org_study_id>
    <nct_id>NCT00487981</nct_id>
  </id_info>
  <brief_title>Spinal Cord Stimulation for Painful Diabetic Neuropathy</brief_title>
  <acronym>DPN</acronym>
  <official_title>Precision Spinal Cord Stimulation for Painful Diabetic Neuropathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate Spinal Cord Stimulation (SCS) therapy in individuals
      who suffer from painful diabetic peripheral neuropathy. Patients invited to participate in
      this study will be eligible for SCS therapy, and will have already selected therapy with the
      Advanced Bionics Precision system independent of possible inclusion in this study. The
      device, accessories, and procedures associated with device placement and the indications for
      use are all consistent with the current and approved product labeling.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The management of neuropathic pain is often difficult, and the available treatment options
      rarely provide complete relief. Although prevention by means of glycemic control is the first
      priority, up to 20% of patients will develop Diabetic Peripheral Neuropathy (DPN) and require
      active drug therapy. Select anti-depressants, anti-epileptics, and opioids have generally
      been the first-line pharmacologic treatments for neuropathic pain. Topical creams have been
      used to achieve local control. Nonconventional therapies have included acupuncture and magnet
      therapy. However, all of these treatments have limited utility because of marginal efficacy.
      Various forms of electric stimulation have been shown to improve the symptoms of DPN.
      Advances in spinal cord stimulation technology have encouraged broader use of this treatment
      modality in the management of chronic painful DPN.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insufficient Data Collected
  </why_stopped>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Rating at 6 Months Post Activation Compared to Baseline</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Diabetic Neuropathy</condition>
  <condition>Pain</condition>
  <condition>Peripheral Neuropathy</condition>
  <arm_group>
    <arm_group_label>Spinal Cord Stimulation Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Spinal Cord Stimulation (SCS) Treatment Group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Precision Spinal Cord Stimulation</intervention_name>
    <description>Stimulation on throughout the study once device is implanted</description>
    <arm_group_label>Spinal Cord Stimulation Group</arm_group_label>
    <other_name>Precision Spinal Cord Stimulation System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have chronic neuropathic pain in at least one limb with a score of at least 3 using
             the Michigan Neuropathy Screening Instrument (MNSI) secondary to Type 1 or Type 2
             diabetes

          -  Have chronic neuropathic pain for at least 12 months

          -  Be 18 years of age or older

          -  Be refractory to pain medication including gabapentin or the use of pain medication is
             contraindicated or not tolerated because of side effects or other medical condition

          -  Be an appropriate candidate for SCS therapy and have already decided to use the
             Precision system

          -  Be willing and able to comply with all study related procedures and visits

          -  Be capable of reading and understanding patient information materials and giving
             written informed consent

        Exclusion Criteria:

          -  Are a smoker

          -  Have any other chronic pain condition likely to confound evaluation of study endpoints

          -  Have any significant medical condition that is likely to interfere with study
             procedures or likely to confound evaluation of study endpoints such as peripheral
             vascular disease or neurological disorders unrelated to diabetic neuropathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francis McDonnell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Deaconess Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Deaconess Pain Management Center</name>
      <address>
        <city>Evansville</city>
        <state>Indiana</state>
        <zip>47747</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 15, 2007</study_first_submitted>
  <study_first_submitted_qc>June 15, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2007</study_first_posted>
  <results_first_submitted>February 13, 2012</results_first_submitted>
  <results_first_submitted_qc>February 21, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 13, 2012</results_first_posted>
  <last_update_submitted>February 21, 2012</last_update_submitted>
  <last_update_submitted_qc>February 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 13, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Implantable stimulation device</keyword>
  <keyword>Neuropathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
    <mesh_term>Diabetic Neuropathies</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Spinal Cord Stimulation (SCS) Group</title>
          <description>Spinal Cord Stimulation (SCS) Treatment Group</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Hypothyroidism diagnosis</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Spinal Cord Stimulation (SCS) Group</title>
          <description>Spinal Cord Stimulation (SCS) Treatment Group</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Rating at 6 Months Post Activation Compared to Baseline</title>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Spinal Cord Stimulation (SCS) Group</title>
            <description>Spinal Cord Stimulation (SCS) Treatment Group</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Rating at 6 Months Post Activation Compared to Baseline</title>
          <units>Percent reduction</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Spinal Cord Stimulation (SCS) Group</title>
          <description>Spinal Cord Stimulation (SCS) Treatment Group</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>One subject enrolled.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Lyn M. Pimentel, M.B.A.</name_or_title>
      <organization>Boston Scientific</organization>
      <phone>(661) 949-4174</phone>
      <email>Lyn.Pimentel@bsci.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

